JPS6237612B2 - - Google Patents

Info

Publication number
JPS6237612B2
JPS6237612B2 JP56086147A JP8614781A JPS6237612B2 JP S6237612 B2 JPS6237612 B2 JP S6237612B2 JP 56086147 A JP56086147 A JP 56086147A JP 8614781 A JP8614781 A JP 8614781A JP S6237612 B2 JPS6237612 B2 JP S6237612B2
Authority
JP
Japan
Prior art keywords
protease
type
allergic diseases
acidic
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56086147A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57206623A (en
Inventor
Haruo Oonishi
Koji Kojaku
Yasuo Suzuki
Suguru Mochida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP56086147A priority Critical patent/JPS57206623A/ja
Priority to CA000395742A priority patent/CA1181005A/en
Priority to AU80290/82A priority patent/AU531314B2/en
Priority to SE8200748A priority patent/SE455163B/sv
Priority to GB8203682A priority patent/GB2095993B/en
Priority to CH782/82A priority patent/CH653557A5/de
Priority to DE8282100973T priority patent/DE3273953D1/de
Priority to NL8200509A priority patent/NL8200509A/nl
Priority to FR8202145A priority patent/FR2499409A1/fr
Priority to IT47761/82A priority patent/IT1154280B/it
Priority to DE19823204631 priority patent/DE3204631A1/de
Priority to EP82100973A priority patent/EP0059346B1/en
Priority to US06/365,465 priority patent/US4540569A/en
Publication of JPS57206623A publication Critical patent/JPS57206623A/ja
Publication of JPS6237612B2 publication Critical patent/JPS6237612B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP56086147A 1981-02-10 1981-06-04 Remedy for allergic disease Granted JPS57206623A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP56086147A JPS57206623A (en) 1981-06-04 1981-06-04 Remedy for allergic disease
CA000395742A CA1181005A (en) 1981-02-10 1982-02-08 Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors
AU80290/82A AU531314B2 (en) 1981-02-10 1982-02-09 Therapeutic agent containing human urinary acid protease
SE8200748A SE455163B (sv) 1981-02-10 1982-02-09 Uropepsin for anvendning som terapeutikum mot allergiska sjukdomar, immunkomplexsjukdomar och tumorer
GB8203682A GB2095993B (en) 1981-02-10 1982-02-09 Compositions containing human urinary acid protease
CH782/82A CH653557A5 (de) 1981-02-10 1982-02-09 Zur behandlung von allergischen zustaenden, immunkomplexkrankheiten und tumoren geeignetes therapeutisches mittel.
DE8282100973T DE3273953D1 (en) 1981-02-10 1982-02-10 Therapeutic agent containing a human urinary pepsin
NL8200509A NL8200509A (nl) 1981-02-10 1982-02-10 Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden.
FR8202145A FR2499409A1 (fr) 1981-02-10 1982-02-10 Agent therapeutique a base d'une protease acide, pour le traitement des troubles allergiques, des maladies avec immunocomplexe et des tumeurs
IT47761/82A IT1154280B (it) 1981-02-10 1982-02-10 Agente terapeutico a base di protea si acida e suo impiego in pazienti affetti da disordini allergici,malattie da immuno-complessi e tumori
DE19823204631 DE3204631A1 (de) 1981-02-10 1982-02-10 Therapeutisches mittel und dessen verwendung
EP82100973A EP0059346B1 (en) 1981-02-10 1982-02-10 Therapeutic agent containing a human urinary pepsin
US06/365,465 US4540569A (en) 1981-02-10 1982-04-05 Method for treatment of allergic disorders and immune complex diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56086147A JPS57206623A (en) 1981-06-04 1981-06-04 Remedy for allergic disease

Publications (2)

Publication Number Publication Date
JPS57206623A JPS57206623A (en) 1982-12-18
JPS6237612B2 true JPS6237612B2 (en]) 1987-08-13

Family

ID=13878617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56086147A Granted JPS57206623A (en) 1981-02-10 1981-06-04 Remedy for allergic disease

Country Status (1)

Country Link
JP (1) JPS57206623A (en])

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239012U (en]) * 1985-08-29 1987-03-09
JPH0594521U (ja) * 1992-05-25 1993-12-24 光洋精工株式会社 止め輪

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2711436B2 (ja) * 1995-02-22 1998-02-10 マルホ株式会社 アレルギー治療剤及びアレルギー対応食品

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239012U (en]) * 1985-08-29 1987-03-09
JPH0594521U (ja) * 1992-05-25 1993-12-24 光洋精工株式会社 止め輪

Also Published As

Publication number Publication date
JPS57206623A (en) 1982-12-18

Similar Documents

Publication Publication Date Title
CN1471974A (zh) 抗炎症剂
US4335099A (en) Employment of enteric coated IgA for hypoproteinemia in intestinal infectious diseases
KR100533399B1 (ko) 경구투여용제제
EP0059346B1 (en) Therapeutic agent containing a human urinary pepsin
JPS6237612B2 (en])
EP0758656B1 (en) Immunoglobulin activated by mixing with a histamine component
EP0100366A1 (en) Agent for treating allergic disease, immunity complex disease, and tumour
Taylor et al. Recurrent pseudo‐scarlatina and allergy to pseudoephedrine hydrochloride
US4591504A (en) Human leucocyte pepsin-like enzyme as a therapeutic agent for treating allergic disorders and immune complex diseases
US4534966A (en) Composition for treating infectious diseases, gout or arteriosclerosis containing human pepsin and/or human leukocyte pepsin-like enzyme and method for using same
JPS6237613B2 (en])
JP3477717B2 (ja) 川崎病予防薬および急性期症状治療薬
US5939072A (en) Herbal composition and method of treating viral infection of the liver
JPS58225026A (ja) アミラ−ゼ活性および／またはリパ−ゼ活性亢進に起因する疾患の予防および治療剤
Kitamura The Department of the Internal Medicine and the Physical Therapy, University of Tokyo Director: Prof. Yoshio Oshima) Infiuences of the anabolic steroids on the production of antibodies and allergic responses in animals were studied and following results were obtained. l. Rabbit were sensitized with egg-albumin and treated simultaneously with various anabolic steroids
JPS6237611B2 (en])
Butler Jr et al. Biologic effects of specific antibodies in reversing the pharmacologic and toxic effects of digoxin
JPS6013717A (ja) 消化器潰瘍治療予防剤
JPS6237614B2 (en])
JPH05163158A (ja) 人尿性キニノゲナーゼを有効成分とする皮膚潰瘍の予防及び治療剤
JPH0585531B2 (en])
WO2007082547A1 (fr) Agent de traitement de la tuberculose oculaire et procédé de production et d'utilisation de celui-ci
JPS60209532A (ja) 若年性関節リウマチ治療剤
JPS63241358A (ja) 肺微小循環部位における損傷の診断法